Key clinical insights from the sudden cardiac death in heart failure trial

Journal of Cardiovascular Nursing

Volumn 21, Issue 6, 2006, Pages 463-468

  Anderson, Jill ^a   Bardy, Gust H ^b  

^a Seattle Institute for Cardiac Research   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Heart failure; Implantable cardioverter defibrillator; SCD HeFT; Sudden cardiac death; Ventricular dysrhythmia

Indexed keywords

AMIODARONE; ANTIARRHYTHMIC AGENT;

AGED; CLINICAL TRIAL; CONGESTIVE HEART FAILURE; CONTROLLED CLINICAL TRIAL; DEFIBRILLATOR; FEMALE; HUMAN; MALE; MIDDLE AGED; RANDOMIZED CONTROLLED TRIAL; REVIEW; SUDDEN DEATH; TREATMENT OUTCOME;

AGED; AMIODARONE; ANTI-ARRHYTHMIA AGENTS; DEATH, SUDDEN, CARDIAC; DEFIBRILLATORS, IMPLANTABLE; FEMALE; HEART FAILURE, CONGESTIVE; HUMANS; MALE; MIDDLE AGED; RANDOMIZED CONTROLLED TRIALS; TREATMENT OUTCOME;

EID: 33846983255     PISSN: 08894655     EISSN: 15505049     Source Type: Journal    
DOI: 10.1097/00005082-200611000-00009     Document Type: Review

References (6)

1. Bardy GH, Lee KL, Mark DB, et al., for the SCD-HeFT Investigators. Amiodarone or implantable cardioverter defibrillator for congestive heart failure. N Engl J Med. 2005;352:225-237.
2. Moss A, Jackson H, Cannom DS, et al. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction (MADIT I). N Engl J Med. 1996;335:1933-1940.
3. Moss A, Zareba W, Jackson Hall W, et al. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction (MADIT II). N Engl J Med. 2002;346:877-883.
4. Doval HC, Nul DR, Grancelli HO, et al. Randomised trial of low-dose amiodarone in severe congestive heart failure (GESICA). Lancet. 1994;344:493-498.
5. Pitt B, Zannad F, Remme WJ, et al. The effect of spironolactone on morbidity and mortality in patients with severe heart failure (RALES). N Engl J Med. 1999;341:709-717.
6. The Writing Committee for the DAVID Trial. Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator. The Dual Chamber and VVI Implantable Defibrillator (DAVID) trial. JAMA. 2002;288:3115-3123.